Scarica l'app Stockscreener
5.19
2.37%
0.12
Dopo l'orario di chiusura:
5.16
-0.03
-0.58%
Clene Inc Borsa (CLNN) Ultime notizie
Best Nanotechnology Stocks To Add to Your WatchlistJanuary 27th - MarketBeat
Top Nanotechnology Stocks To Follow NowJanuary 26th - MarketBeat
Breakout Watch: Will Clene Inc benefit from AI trendsPortfolio Gains Summary & Capital Protection Trade Alerts - baoquankhu1.vn
Promising Nanotechnology Stocks To Follow TodayJanuary 25th - MarketBeat
Aug Breakouts: Should I buy Tile Shop Holdings Inc stock now2025 Trading Volume Trends & AI Based Trade Execution Alerts - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayJanuary 24th - MarketBeat
Chidozie Ugwumba Sells 12,665 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 5,556 Shares of Stock - MarketBeat
Technical Analysis: How do insiders feel about Clene Inc Equity WarrantQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Promising Nanotechnology Stocks To Watch NowJanuary 23rd - MarketBeat
Clene Inc. (NASDAQ:CLNN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Clene Conference: FDA Grants Type C Meeting as CLNN Eyes ALS CNM-Au8 Accelerated Approval in Q2 - Yahoo Finance
Nanotechnology Stocks To Watch NowJanuary 22nd - MarketBeat
Chidozie Ugwumba Sells 12,119 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 7,923 Shares - MarketBeat
Chidozie Ugwumba Sells 12,432 Shares of Clene (NASDAQ:CLNN) Stock - MarketBeat
Clene Inc. ten percent owner sells $161k in shares By Investing.com - Investing.com Australia
Clene Inc. ten percent owner sells $161k in shares - Investing.com
CLNN: FDA to review ALS therapy data this quarter; NDA filing and commercialization targeted for 2025 - TradingView
Should I hold or sell Regency Centers Corporation nowQuarterly Trade Report & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Top Nanotechnology Stocks To Follow TodayJanuary 8th - MarketBeat
Insider Buy: What is the PEG ratio of Clene Inc2025 Trading Recap & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream - Investing News Network
Promising Nanotechnology Stocks To Add to Your WatchlistJanuary 18th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistJanuary 4th - MarketBeat
Nanotechnology Stocks Worth WatchingJanuary 17th - MarketBeat
Growth Value: Will PG E Corporation Preferred Security benefit from rising consumer demandSell Signal & Intraday High Probability Alerts - baoquankhu1.vn
Clene Inc. ten percent owner sells $292,184 in shares By Investing.com - Investing.com Australia
Trading Action: Is Clene Inc exposed to currency risksEarnings Growth Report & High Conviction Investment Ideas - baoquankhu1.vn
Shorts Report: Will CLNN stock recover after earningsMarket Movement Recap & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Technicals: Is Clene Inc Equity Warrant stock a smart retirement pickWeekly Risk Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingJanuary 16th - MarketBeat
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 19,621 Shares of Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Chidozie Ugwumba Sells 26,105 Shares - MarketBeat
Clene Inc. ten percent owner sells $292,184 in shares - Investing.com
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks To Follow TodayJanuary 15th - MarketBeat
Clene, FDA to discuss survival data and approval path for CNM-Au8 - ALS News Today
Winners Losers: Is Clene Inc a top pick in the sectorGap Up & Long-Term Growth Stock Strategies - baoquankhu1.vn
Risks Report: Is Clene Inc Equity Warrant stock positioned well for digital economyWeekly Profit Summary & AI Forecasted Entry/Exit Points - Bộ Nội Vụ
Clene (NASDAQ:CLNN) Director David Matlin Purchases 33,333 Shares of Stock - MarketBeat
Insider Buying: David Matlin Acquires Shares of Clene Inc (CLNN) - GuruFocus
Clene Announces Multi-Tranche Financing to Extend Cash Runway - TipRanks
Clene Signs Multiple Financing Agreements - TradingView
Forecast Cut: Is Clene Inc. stock dividend yield sustainableQuarterly Profit Report & High Accuracy Investment Entry Signals - Bộ Nội Vụ
Promising Nanotechnology Stocks To Follow NowJanuary 13th - MarketBeat
FDA grants Clene in-person meeting to discuss ALS drug biomarker data - Investing.com Nigeria
Published on: 2026-01-13 07:04:12 - Улправда
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells $19,457.55 in Stock - MarketBeat
Clene Inc. ten percent owner sells $256k in shares - Investing.com
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 32,705 Shares of Stock - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Sells $56,900.25 in Stock - MarketBeat
Clene Inc. ten percent owner sells $256k in shares By Investing.com - Investing.com India
Clene Insider Sold Shares Worth $256,235, According to a Recent SEC Filing - marketscreener.com
Nanotechnology Stocks To ResearchJanuary 12th - MarketBeat
Clene (CLNN) Secures FDA Type C Meeting for ALS Treatment Review - GuruFocus
Clene Advances CNM-Au8 ALS Program with FDA Meeting - TipRanks
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):